Category: Lung cancer

Last fall, Merck & Company (Merck & Co) revealed new clinical data that showed its immunotherapy drug Keytruda was showing positive benefits in lung cancer patients who were previously untreated, according to a FoxNews report. Keytruda, the study showed, was given to patients either on its on or in combination with chemotherapy. The American Cancer […]

Lung cancer is a type of malignant, or invasive, tumor that generates in the lungs. Research shows that this disease leads to the deaths of as many as 160,000 individuals each year in the United States. While smoking has been identified as the most common cause of lung cancer, those who are exposed to certain […]

Cancer of the lungs is a type of malignant tumor that starts in the lungs. According to research, this disease is the cause of about 160,000 deaths in the United States each year. While smoking is recognized as the most common cause of cancer of the lungs, working with or being near particular hazardous materials […]

A global manufacturer of sustainable and high-performing glass based products, Pittsburgh Corning Corporation (“Corning”), was forced to pay a multi-billion dollar asbestos lung cancer settlement last year. A personal injury trust fund valued at $3.5 billion, according to GlobeNewswire, was established to resolve the asbestos claims. The company emerged from Chapter 11 Bankruptcy protection recently, […]